Market Cap 419.71M
Revenue (ttm) 0.00
Net Income (ttm) -124.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 715,006
Avg Vol 1,150,258
Day's Range N/A - N/A
Shares Out 77.87M
Stochastic %K 58%
Beta 2.54
Analysts Strong Sell
Price Target $15.42

Company Profile

Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It also develops SGT-212 for the treatment of Friedreich's ataxia that is in phase 1b clinical trial; SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia that is in preclinical phase; SGT-601 the treatment of TNNT2-mediated dilated cardiomyopath...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 337 4680
Address:
500 Rutherford Avenue, Third Floor, Charlestown, United States
highnihilism
highnihilism Sep. 16 at 7:51 PM
IWM: Russell 2000 → $SLDB Solid Biosciences $OII Oceaneering $ANDE Andersons $AGL Agilon Health $LOCO El Pollo Loco
0 · Reply
Bio_Invest101
Bio_Invest101 Sep. 12 at 9:22 PM
$SLDB $SRPT Seems Adcom won’t be needed any more from outside experts… https://www.fiercepharma.com/pharma/under-trump-fda-seeks-abandon-expert-reviews-new-drugs
1 · Reply
Bio_Invest101
Bio_Invest101 Sep. 11 at 11:10 AM
$SLDB SI are still close to record high.
0 · Reply
flexdiggs
flexdiggs Sep. 10 at 6:22 PM
$SLDB they really tried to shake the tree here, company is on track with their trials and money. Steady as she goes, we'll see a breakout soon, gl.
1 · Reply
Impatient_Investor
Impatient_Investor Sep. 10 at 7:23 AM
$SLDB pump and dump garbage
1 · Reply
Stmkr
Stmkr Sep. 10 at 3:51 AM
$SLDB - Lower dose - Higher skeleral and cardiac muscle transduction - No hepatotoxity (single Gr1 case among first 15 patients treated). No TMA. No myocarditis - Only (?) DMD construct with nNOS domain - Only corticosteroids (no need for more intensive immunossuppression) - Potential to re-dose Elevidys treated patient - regulatory feedback for AA later this year Anything else as good / better out there?
0 · Reply
MobyDick2324
MobyDick2324 Sep. 9 at 4:53 PM
$SLDB Nothing exciting until Q4: - Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to discuss regulatory pathways with U.S. FDA in Q4 2025 - - FA (SGT-212): Phase 1b trial initiation expected in Q4 2025 - - CPVT (SGT-501): Phase 1b trial initiation expected in Q4 2025 -
1 · Reply
Thr0winDarts
Thr0winDarts Sep. 9 at 4:19 PM
$SLDB who’s ready to capitulate?
0 · Reply
Thr0winDarts
Thr0winDarts Sep. 9 at 2:44 PM
$SLDB going to bleed into the 3s without any announcement
1 · Reply
Impatient_Investor
Impatient_Investor Sep. 9 at 7:54 AM
$SLDB pump and dump garbage
0 · Reply
Latest News on SLDB
Solid Biosciences Announces Pricing of Underwritten Offering

Feb 18, 2025, 7:00 AM EST - 7 months ago

Solid Biosciences Announces Pricing of Underwritten Offering


Solid Biosciences Added to the Nasdaq Biotechnology Index

Dec 23, 2024, 4:05 PM EST - 9 months ago

Solid Biosciences Added to the Nasdaq Biotechnology Index


Buy Solid Biosciences: Unpacking Its Main Value Driver

Apr 10, 2024, 7:32 PM EDT - 1 year ago

Buy Solid Biosciences: Unpacking Its Main Value Driver


Solid Biosciences Announces $109 Million Private Placement

Jan 8, 2024, 7:09 AM EST - 1 year ago

Solid Biosciences Announces $109 Million Private Placement


highnihilism
highnihilism Sep. 16 at 7:51 PM
IWM: Russell 2000 → $SLDB Solid Biosciences $OII Oceaneering $ANDE Andersons $AGL Agilon Health $LOCO El Pollo Loco
0 · Reply
Bio_Invest101
Bio_Invest101 Sep. 12 at 9:22 PM
$SLDB $SRPT Seems Adcom won’t be needed any more from outside experts… https://www.fiercepharma.com/pharma/under-trump-fda-seeks-abandon-expert-reviews-new-drugs
1 · Reply
Bio_Invest101
Bio_Invest101 Sep. 11 at 11:10 AM
$SLDB SI are still close to record high.
0 · Reply
flexdiggs
flexdiggs Sep. 10 at 6:22 PM
$SLDB they really tried to shake the tree here, company is on track with their trials and money. Steady as she goes, we'll see a breakout soon, gl.
1 · Reply
Impatient_Investor
Impatient_Investor Sep. 10 at 7:23 AM
$SLDB pump and dump garbage
1 · Reply
Stmkr
Stmkr Sep. 10 at 3:51 AM
$SLDB - Lower dose - Higher skeleral and cardiac muscle transduction - No hepatotoxity (single Gr1 case among first 15 patients treated). No TMA. No myocarditis - Only (?) DMD construct with nNOS domain - Only corticosteroids (no need for more intensive immunossuppression) - Potential to re-dose Elevidys treated patient - regulatory feedback for AA later this year Anything else as good / better out there?
0 · Reply
MobyDick2324
MobyDick2324 Sep. 9 at 4:53 PM
$SLDB Nothing exciting until Q4: - Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to discuss regulatory pathways with U.S. FDA in Q4 2025 - - FA (SGT-212): Phase 1b trial initiation expected in Q4 2025 - - CPVT (SGT-501): Phase 1b trial initiation expected in Q4 2025 -
1 · Reply
Thr0winDarts
Thr0winDarts Sep. 9 at 4:19 PM
$SLDB who’s ready to capitulate?
0 · Reply
Thr0winDarts
Thr0winDarts Sep. 9 at 2:44 PM
$SLDB going to bleed into the 3s without any announcement
1 · Reply
Impatient_Investor
Impatient_Investor Sep. 9 at 7:54 AM
$SLDB pump and dump garbage
0 · Reply
Bio_Invest101
Bio_Invest101 Sep. 6 at 4:11 AM
$IOVA Just insanely unbelievable!! https://www.datainsightsmarket.com/news/article/fda-taps-biotech-vet-dr-nicole-verdun-as-new-cder-director-83958 $SLDB
3 · Reply
Bio_Invest101
Bio_Invest101 Sep. 3 at 8:46 PM
$SLDB Better time ahead https://www.fiercebiotech.com/biotech/fda-proposal-would-allow-single-arm-trials-confirmatory-evidence-ultra-rare-diseases
0 · Reply
Bio_Invest101
Bio_Invest101 Sep. 3 at 3:33 PM
$SLDB https://www.youtube.com/watch?v=qNhYlLR-u0Q
0 · Reply
Impatient_Investor
Impatient_Investor Aug. 29 at 7:35 PM
0 · Reply
pharmd2828
pharmd2828 Aug. 28 at 10:09 PM
0 · Reply
GammaRadiated
GammaRadiated Aug. 28 at 3:03 PM
$SLDB Looks like Bo is talking in 4 live fireside investor chats next 4-10 days - good news coming? https://finance.yahoo.com/news/solid-biosciences-participate-upcoming-investor-120000536.html
0 · Reply
Thr0winDarts
Thr0winDarts Aug. 27 at 5:21 PM
$SLDB hardest part of trading these small cap bios is the manipulation they undergo. This stock was systematically brought down from $10 in August 2024 to 2.80 in Feb 2025. Then, just like clockwork, it mysteriously starts increasing in volume for 5 days and moves from 2.80 to 4.20. It was as if the powers that be knew something was happening and covered their short position ahead of time. The following day data was released and it jumps to 7.20. Trading these companies where manipulation is so blatant and the playing field so uneven is very difficult. The reality now is data will be dumped again and the powers that be will know. Expect it to continue being run down and another spike in volume and price right before so they can cover their short position. It might not go under $3 again, but it likely will continue falling on low volume as long as nothing is announced.
1 · Reply
pharmd2828
pharmd2828 Aug. 27 at 4:58 PM
$SLDB some short sellers have covered per data dated 8/15! 1 m less short compared to 7/31/25! Cover b4 you shorts get crushed by coming tsunami …. Imho
0 · Reply
Thr0winDarts
Thr0winDarts Aug. 26 at 6:06 PM
$SLDB imagine we should be getting more data soon. Had 180 day data in Feb for two patients. Expect 360 day day to drop for them soon along with more 180 and 90 day data for newer participants
0 · Reply
pharmd2828
pharmd2828 Aug. 26 at 4:59 PM
$SLDB she is sitting on a lunch pad imho !!
0 · Reply
Thr0winDarts
Thr0winDarts Aug. 25 at 7:20 PM
$SLDB pretty impressive how they can walk it down on such low volume. Shows how awful liquitity is for the stock.
0 · Reply
Bio_Invest101
Bio_Invest101 Aug. 25 at 2:26 AM
$IRWD A Short clip but worth of the retails to remember what roles we play in the whole game. BLTA https://stocktwits.com/Bio_Invest101/message/626386428 $DAWN $SLDB
0 · Reply